In vitro activities of the ketolide HMR 3647 against recent gram-positive clinical isolates and Haemophilus influenzae

被引：58
|
作者：
Barry, AL [1 ]
Fuchs, PC [1 ]
Brown, SD [1 ]
机构：
[1] Inst Clin Microbiol, Wilsonville, OR 97070 USA
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1998年 / 42卷 / 08期
关键词：
D O I：
10.1128/AAC.42.8.2138
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
The ketolide HMR 3647 (previously RU 66647) was evaluated against 2,563 recent clinical isolates of gram-positive pathogens and 200 Haemophilus influenzae isolates. HMR 3647 was active against macrolide-resistant streptococci, including pneumococci, but was not active against macrolide- or lincosamide-resistant staphylococci. Against H. influenzae, the potency of HMR 3647 was similar to that of azithromycin.
引用
下载
收藏
页码：2138 / 2140
页数：3
相关论文
共 50 条
  • [31] In vitro activities of a new ketolide, ABT-773, against multidrug-resistant gram-positive cocci
    Singh, KV
    Malathum, K
    Murray, BE
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (12) : 3640 - 3643
  • [32] In vitro activity of RU 64004, a new ketolide antibiotic, against gram-positive bacteria
    Schulin, T
    Wennersten, CB
    Moellering, RC
    Eliopoulos, GM
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) : 1196 - 1202
  • [33] IN-VITRO ACTIVITY OF BIAPENEM AGAINST CLINICAL ISOLATES OF GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA
    MALANOSKI, GJ
    COLLINS, L
    WENNERSTEN, C
    MOELLERING, RC
    ELIOPOULOS, GM
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (09) : 2009 - 2016
  • [34] Comparative in vitro activity of gemifloxacin against gram-positive and gram-negative clinical isolates in Argentina
    Lopez, H
    Stepanik, D
    Vilches, V
    Scarano, S
    Sarachian, B
    Mikaelian, G
    Finlay, J
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2001, 40 (04) : 187 - 192
  • [35] In vitro activity of telavancin against gram-positive clinical isolates recently obtained in Europe
    Jansen, W. T. A.
    Verel, A.
    Verhoef, J.
    Milatovic, D.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (09) : 3420 - 3424
  • [36] Comparative in-vitro activities of quinupristin-dalfopristin against Gram-positive bloodstream isolates
    Schouten, MA
    HoogkampKorstanje, JAA
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (02) : 213 - 219
  • [37] Daptomycin in vitro susceptibility in European Gram-positive clinical isolates
    Fluit, AC
    Schmitz, FJ
    Verhoef, J
    Milatovic, D
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 (01) : 59 - 66
  • [38] Postantibiotic suppression of growth of erythromycin A-susceptible and -resistant gram-positive bacteria by the ketolides telithromycin (HMR 3647) and HMR 3004
    Munckhof, WJ
    Borlace, G
    Turnidge, JD
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (06) : 1749 - 1753
  • [39] In vitro susceptibility of recent Gram-positive isolates to ciprofloxacin, levofloxacin, and trovafloxacin
    Isenberg, HD
    Alperstein, P
    France, K
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1998, 32 (02) : 115 - 118
  • [40] Relative potency of telithromycin, azithromycin and erythromycin against recent clinical isolates of gram-positive cocci
    Barry, AL
    Fuchs, PC
    Brown, SD
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2001, 20 (07) : 494 - 497
12345